SFM
ZYME icon

Sphera Funds Management’s Zymeworks ZYME Stock Holding History

Sphera Funds Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-245,000
Closed -$11.6M – 206
2020
Q4 		$11.6M Buy
245,000
+165,000
+206% +$7.66M 1.03% 23
2020
Q3 		$3.73M Sell
80,000
-36,310
-31% -$1.25M 0.37% 67
2020
Q2 		$4.2M Sell
116,310
-90,520
-44% -$3.33M 0.39% 56
2020
Q1 		$7.34M Buy
206,830
+49,830
+32% +$2.04M 0.92% 25
2019
Q4 		$7.14M Sell
157,000
-13,000
-8% -$472K 0.59% 38
2019
Q3 		$4.22M Buy
+170,000
New +$4.26M 0.65% 48
2018
Q4 		– Sell
-73,800
Closed -$1.16M – 128
2018
Q3 		$1.16M Hold
73,800
– – 0.13% 92
2018
Q2 		$1.09M Buy
+73,800
New +$1.14M 0.15% 89

Other funds holding ZYME

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sphera Funds Management's ZYME Position: Q1 2021 in Review

Sphera Funds Management sold out of Zymeworks (ZYME) in Q1 2021, closing a stake of 245,000 shares — an estimated $11.6M sold.

Sphera Funds Management first reported a position in ZYME in Q2 2018 and held it in 8 quarters. The position peaked at $11.6M in Q4 2020. 125 funds tracked by Wall St. Rank hold ZYME as of Q1 2021.

  • Sphera Funds Management reported no remaining Zymeworks position as of Q1 2021 after selling out during the quarter.
  • Sphera Funds Management sold 245,000 Zymeworks shares in Q1 2021, an estimated $11.6M.
  • Sphera Funds Management first reported a position in Zymeworks in Q2 2018 and held it in 8 quarters.
  • Sphera Funds Management's Zymeworks position peaked at $11.6M in Q4 2020.
  • 125 funds tracked by Wall St. Rank held Zymeworks as of Q1 2021.

Based on Sphera Funds Management's 13F filing for Q1 2021, filed 17 May 2021.